Open access
Open access
Powered by Google Translator Translator

Randomized Trial: Neoadjuvant Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

27 Aug, 2019 | 00:09h | UTC

Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study – Journal of Clinical Oncology (free)

Commentary: Neoadjuvant Radiotherapy vs Surgery Alone for Resectable Hepatocellular Carcinoma With Tumor Thrombus – The ASCO Post (free)

Source: EvidenceAlerts

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.